Oct 10 Love0 Once-Monthly MariTide (AMG-133): New Hope in Durable Obesity Treatment By Damian Williams Medical Weight Loss Takeaways Once-monthly MariTide led to up to 17.5% weight loss in 52 weeks, with minimal regain after stopping treatment. The drug combines GLP-1 and glucagon receptor activity, offering fat burn and appetite suppression…Read More